Related Experiment Videos
Current practices in generation of small molecule new leads
1New Leads Chemistry Initiative, Roche Research Center, Nutley, New Jersey 07110-1199, USA. robert.goodnow@roche.com
Journal of Cellular Biochemistry. Supplement
|February 14, 2002
Summary
Pharmaceutical companies need large, diverse compound collections for drug discovery. New strategies focus on targeted library design and synthesis to accelerate the identification and optimization of novel lead structures.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Chemical Biology
Background:
- Drug discovery relies on extensive, high-quality compound collections for high-throughput screening (HTS).
- Historically, compound libraries were sourced from internal archives, external vendors, or mergers.
- Current trends involve dedicated synthesis of targeted compound libraries for novel lead generation.
Purpose of the Study:
- To discuss strategies, trends, and critical issues in modern drug lead generation.
- To highlight the importance of targeted library design and synthesis.
- To emphasize the benefits of screening diverse compound libraries against biological targets.
Main Methods:
- Review of current practices in pharmaceutical lead generation.
- Discussion of high-throughput chemistry (HTC) and combinatorial chemistry applications.
- Analysis of structure-activity relationship (SAR) data derived from lead generation libraries.
Main Results:
- The selection and design of compound libraries are increasingly critical and challenging.
- Screening diverse small molecule libraries against multiple targets offers significant potential for discovering new leads.
- Lead optimization is accelerated by SAR information and the applicability of HTC methods.
Conclusions:
- Targeted synthesis and advanced library design are crucial for efficient drug discovery.
- Integrating SAR data early in the process streamlines lead optimization.
- The evolution of lead generation strategies is key to pharmaceutical innovation.